Senecavirus A (SVA) and Foot-and-Mouth Disease Virus (FMDV) are significant viral pathogens that cause major economic losses in livestock, particularly in pigs and cattle. This study investigates the inhibitory effects of bovine lactoferricin-lactoferrampin (bLFcin-LFamp) peptides on SVA and FMDV, delivered through recombinant Lactobacillus oral treatment in mice. The peptides' antiviral activity was evaluated in vitro and in vivo, with Lactobacillus engineered to express bLFcin-LFamp as a delivery vehicle. The results demonstrated that the recombinant Lactobacillus significantly reduced viral replication and clinical symptoms in mice infected with both SVA and FMDV. This study suggests that bLFcin-LFamp peptides, when delivered via oral Lactobacillus treatment, represent a promising therapeutic strategy for controlling viral infections in livestock.

Bovine lactoferricin, lactoferrampin, Senecavirus

Grubman, M.J.; Baxt, B. Foot-and-mouth disease. Clin. Microbiol. Rev. 2004, 17, 465–493. [Google Scholar] [CrossRef] [PubMed]

Bauer, K. Foot- and-mouth disease as zoonosis. Arch. Virol. Suppl. 1997, 13, 95–97. [Google Scholar] [CrossRef] [PubMed]

Aslam, M.; Alkheraije, K.A. The prevalence of foot-and-mouth disease in Asia. Front. Vet. Sci. 2023, 10, 1201578. [Google Scholar] [CrossRef] [PubMed]

Arzt, J.; Pacheco, J.M.; Stenfeldt, C.; Rodriguez, L.L. Pathogenesis of virulent and attenuated foot-and-mouth disease virus in cattle. Virol. J. 2017, 14, 89. [Google Scholar] [CrossRef]

Leme, R.A.; Zotti, E.; Alcântara, B.K.; Oliveira, M.V.; Freitas, L.A.; Alfieri, A.F.; Alfieri, A.A. Senecavirus A: An Emerging Vesicular Infection in Brazilian Pig Herds. Transbound. Emerg. Dis. 2015, 62, 603–611. [Google Scholar] [CrossRef]

Segalés, J.; Barcellos, D.; Alfieri, A.; Burrough, E.; Marthaler, D. Senecavirus A. Vet. Pathol. 2017, 54, 11–21. [Google Scholar] [CrossRef]

Ran, X.; Hu, Z.; Wang, J.; Yang, Z.; Li, Z.; Wen, X. Prevalence of Senecavirus A in pigs from 2014 to 2020: A global systematic review and meta-analysis. J. Vet. Sci. 2023, 24, e48. [Google Scholar] [CrossRef]

Preis, G.; Sanhueza, J.M.; Vilalta, C.; Vannucci, F.A.; Culhane, M.R.; Corzo, C.A. Senecavirus A seroprevalence and risk factors in United States pig farms. Front. Vet. Sci. 2022, 9, 1011975. [Google Scholar] [CrossRef]

Wu, H.; Li, C.; Ji, Y.; Mou, C.; Chen, Z.; Zhao, J. The Evolution and Global Spatiotemporal Dynamics of Senecavirus A. Microbiol. Spectr. 2022, 10, e0209022. [Google Scholar] [CrossRef]

Dee, S.; Havas, K.; Spronk, G. Detection of Senecavirus A in pigs from a historically negative national swine herd and associated with feed imports from endemically infected countries. Transbound. Emerg. Dis. 2022, 69, 3147–3149. [Google Scholar] [CrossRef]

Drago-Serrano, M.E.; Campos-Rodriguez, R.; Carrero, J.C.; de la Garza, M. Lactoferrin and Peptide-derivatives: Antimicrobial Agents with Potential Use in Nonspecific Immunity Modulation. Curr. Pharm. Des. 2018, 24, 1067–1078. [Google Scholar] [CrossRef]

Masson, P.L.; Heremans, J.F. Lactoferrin in milk from different species. Comp. Biochem. Physiol. B Comp. Biochem. 1971, 39, 119–129. [Google Scholar] [CrossRef] [PubMed]

Hennart, P.F.; Brasseur, D.J.; Delogne-Desnoeck, J.B.; Dramaix, M.M.; Robyn, C.E. Lysozyme, lactoferrin, and secretory immunoglobulin A content in breast milk: Influence of duration of lactation, nutrition status, prolactin status, and parity of mother. Am. J. Clin. Nutr. 1991, 53, 32–39. [Google Scholar] [CrossRef] [PubMed]

Yamauchi, K.; Tomita, M.; Giehl, T.J.; Ellison, R.T., 3rd. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect. Immun. 1993, 61, 719–728. [Google Scholar] [CrossRef] [PubMed]

Avery, T.M.; Boone, R.L.; Lu, J.; Spicer, S.K.; Guevara, M.A.; Moore, R.E.; Chambers, S.A.; Manning, S.D.; Dent, L.; Marshall, D.; et al. Analysis of Antimicrobial and Antibiofilm Activity of Human Milk Lactoferrin Compared to Bovine Lactoferrin against Multidrug Resistant and Susceptible Acinetobacter baumannii Clinical Isolates. ACS Infect. Dis. 2021, 7, 2116–2126. [Google Scholar] [CrossRef]

Flores-Villaseñor, H.; Canizalez-Román, A.; Reyes-Lopez, M.; Nazmi, K.; de la Garza, M.; Zazueta-Beltrán, J.; León-Sicairos, N.; Bolscher, J.G. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli. Biometals Int. J. Role Met. Ions Biol. Biochem. Med. 2010, 23, 569–578. [Google Scholar] [CrossRef]

Pietrantoni, A.; Di Biase, A.M.; Tinari, A.; Marchetti, M.; Valenti, P.; Seganti, L.; Superti, F. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob. Agents Chemother. 2003, 47, 2688–2691. [Google Scholar] [CrossRef]

Jeong, Y.Y.; Lee, G.Y.; Yoo, Y.C. Bovine Lactoferricin Induces Intestinal Epithelial Cell Activation through Phosphorylation of FAK and Paxillin and Prevents Rotavirus Infection. J. Microbiol. Biotechnol. 2021, 31, 1175–1182. [Google Scholar] [CrossRef]

Bellamy, W.; Wakabayashi, H.; Takase, M.; Kawase, K.; Shimamura, S.; Tomita, M. Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Med. Microbiol. Immunol. 1993, 182, 97–105. [Google Scholar] [CrossRef]

Nakamura, A.; Kimura, F.; Tsuji, S.; Hanada, T.; Takebayashi, A.; Takahashi, A.; Kitazawa, J.; Morimune, A.; Amano, T.; Kushima, R.; et al. Bovine lactoferrin suppresses inflammatory cytokine expression in endometrial stromal cells in chronic endometritis. J. Reprod. Immunol. 2022, 154, 103761. [Google Scholar] [CrossRef]